WO2023223083A1 - Cultured meat production process, materials and equipment - Google Patents
Cultured meat production process, materials and equipment Download PDFInfo
- Publication number
- WO2023223083A1 WO2023223083A1 PCT/IB2022/054758 IB2022054758W WO2023223083A1 WO 2023223083 A1 WO2023223083 A1 WO 2023223083A1 IB 2022054758 W IB2022054758 W IB 2022054758W WO 2023223083 A1 WO2023223083 A1 WO 2023223083A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cross
- cell
- linkable
- process according
- gel material
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 94
- 235000013372 meat Nutrition 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 51
- 238000004132 cross linking Methods 0.000 claims abstract description 47
- 210000001519 tissue Anatomy 0.000 claims abstract description 31
- 239000001963 growth medium Substances 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 230000003387 muscular Effects 0.000 claims abstract description 10
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims abstract description 7
- 235000013622 meat product Nutrition 0.000 claims abstract description 5
- 239000000725 suspension Substances 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 130
- 239000000499 gel Substances 0.000 claims description 92
- 238000000034 method Methods 0.000 claims description 70
- 230000008569 process Effects 0.000 claims description 55
- 239000000243 solution Substances 0.000 claims description 33
- 239000000017 hydrogel Substances 0.000 claims description 18
- 230000010261 cell growth Effects 0.000 claims description 13
- 238000001125 extrusion Methods 0.000 claims description 13
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 claims description 12
- 239000000872 buffer Substances 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 210000001057 smooth muscle myoblast Anatomy 0.000 claims description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 7
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 7
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 7
- 229940072056 alginate Drugs 0.000 claims description 7
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 229920000615 alginic acid Polymers 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 7
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 108700004892 gelatin methacryloyl Proteins 0.000 claims description 6
- 229920000620 organic polymer Polymers 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 210000003098 myoblast Anatomy 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 230000003068 static effect Effects 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 239000002953 phosphate buffered saline Substances 0.000 claims description 4
- 239000004633 polyglycolic acid Substances 0.000 claims description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- 210000002744 extracellular matrix Anatomy 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000271566 Aves Species 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 239000004971 Cross linker Substances 0.000 claims description 2
- 241000238424 Crustacea Species 0.000 claims description 2
- 102000016942 Elastin Human genes 0.000 claims description 2
- 108010014258 Elastin Proteins 0.000 claims description 2
- 108010073385 Fibrin Proteins 0.000 claims description 2
- 102000009123 Fibrin Human genes 0.000 claims description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 241000282898 Sus scrofa Species 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 210000001789 adipocyte Anatomy 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 2
- 230000021164 cell adhesion Effects 0.000 claims description 2
- 125000004386 diacrylate group Chemical group 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 229920002549 elastin Polymers 0.000 claims description 2
- 229950003499 fibrin Drugs 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 230000007246 mechanism Effects 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 210000000107 myocyte Anatomy 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 244000144977 poultry Species 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 235000015170 shellfish Nutrition 0.000 claims description 2
- 239000001488 sodium phosphate Substances 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 2
- 229920003169 water-soluble polymer Polymers 0.000 claims description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 239000000835 fiber Substances 0.000 description 24
- 239000000976 ink Substances 0.000 description 22
- 230000012010 growth Effects 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 7
- 239000012510 hollow fiber Substances 0.000 description 7
- 230000003833 cell viability Effects 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 5
- JUYQFRXNMVWASF-UHFFFAOYSA-M lithium;phenyl-(2,4,6-trimethylbenzoyl)phosphinate Chemical compound [Li+].CC1=CC(C)=CC(C)=C1C(=O)P([O-])(=O)C1=CC=CC=C1 JUYQFRXNMVWASF-UHFFFAOYSA-M 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000013019 agitation Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RFKQJTRWODZPHF-UHFFFAOYSA-N Dehydrocorydaline Chemical compound COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C(C)=C3C2=C1 RFKQJTRWODZPHF-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 229960003942 amphotericin b Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000000739 chaotic effect Effects 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003125 immunofluorescent labeling Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 235000021232 nutrient availability Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Natural products CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241001034916 Corydalis turtschaninovii Species 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 238000002737 cell proliferation kit Methods 0.000 description 1
- 238000012200 cell viability kit Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004512 die casting Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000005487 simulated microgravity Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/78—Cellulose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
- C12N2537/10—Cross-linking
Definitions
- the invention pertains to the field of food production and tissue engineering and particularly refers to the production of meat by cell culture and the equipment required to implement the same.
- Meat culture has been developed over the years as an alternative to animal sacrifices by establishing processes that enable the growth of muscular tissue from stem cells that grow on structures or patterns so-called scaffolds that allow the adhesion of the differentiated cells and its growth to form tissue that is similar to the tissue of meat obtained from sacrificed animals, a process that corresponds to the field known as tissue engineering.
- tissue engineering has been developed mainly to enable tissue restoration for medical applications, the majority of which lead to a scaffold that has cells, embedded or adhered, capable of differentiating to the target tissue, such as bone, cartilage or organs such as kidney, liver, nerves, heart muscle or pancreas among others.
- liver tissue generation is of interest, such as the case of publication number JP2017085945.
- JP2017085945 describes three-dimensional culturing of cells by inoculating a biodegradable scaffold material with a hepatocyte, and endothelial cell and a mesenchymal stem cell, and the culturing them therein under a simulated microgravity environment, which is also very complex to get for large scale production of meat.
- 3D scaffold printing is one of the most used techniques in tissue engineering, which includes typically the need to prepare an ink with proper materials through a mixing equipment and then extruding it onto a surface or a liquid to conform scaffolds or structures that will be used, once formed, to grow the cells of interest therein. Under these conditions cells are adhered to the outer surface of the scaffolds and even in porous materials they will not take advantage of the whole available holes or hollow spaces within the scaffold.
- Such scaffold is produced by depositing a drop of a polymer solution on a chilled surface, which will make it freeze into semi-spherical scaffold particles, which are then dried through lyophilization for use in a further process where the cells are put in contact with the so obtained scaffolds for obtaining the cultured meat.
- This process has several disadvantages for scaling up, including the use of lyophilization and the need to use equipment for cooling the bed where the biopolymer is dropped on, which makes it expensive, and it keeps the need to embed the scaffold with the cells for growth in a further processing step and limits the growth of the cells as these are typically adhered predominantly to the surface of the scaffold.
- the edibility of the scaffolding material is one of the targets to achieve, and there are other scaffolds in the prior art that are biocompatible and might be edible, such as that described in publication CN106110402 where cells for human skin are constructed within a sodium alginate hydrogel scaffold and then grown in a layer structure as sheets for application to wounds.
- bio-ink in this context is understood as a mixture of components that in addition to the scaffolding materials as described before, also includes a biological material before it is otherwise formed so that it is possible to provide a pattern for growth with the cells embedded therein.
- the methods described therein comprise providing a bio-ink composition and a fugitive ink composition followed by a chaotic printing process to generate a micro- structured precursor comprising a plurality of lamellar structures formed from the bio-ink composition in order to obtain fiber/filament shapes.
- the bio-ink composition is then cured to form a scaffold precursor and finally the fugitive ink is removed from the cured scaffold precursor, thereby forming a perfusable fiber-shaped scaffold.
- this technique is also very difficult to use in meat culture since the flow control required is a burden to obtain large volumes of the scaffold faster, even if the cells are diffused prior to the bioprinting process through extrusion.
- the same document describes a complex bioreactor structure for the scaffolds thereby obtained, which prevents the possibility of obtaining a high volume of meat as a result, as the lamellar materials thereby obtained require careful handling to keep its integrity after extrusion, and do not resist shear stresses for more efficient culture processes requiring mixing.
- It an additional object of the present invention to provide a scaffold that allows cells to grow within the scaffold and not only on the surfaces that increase the shear stress resistance of the culture during cell growth.
- a cultured meat production process comprising the steps of: a) mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) letting the cell-gel mixture drop into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross-linkable material; c) cross-linking the cell-gel mixture by keeping a suspension of cell-gel mixture droplets in the crosslinking solution until cross-linking is achieved thereby obtaining spherical cell-loaded edible scaffolds; d) removing the cross-linking solution with the non-cross-linkable gel material; e) growing the cells in the cell-loaded edible scaffolds in culture media; and f) removing the culture media to obtain tissue spheres.
- the cell-loaded edible scaffolds obtained by the process of the invention thereby obtained have preferably a diameter bigger than 3 mm which allows cells to grow within the scaffold and not only on the surface, thereby maximizing nutrient availability and therefore cell growth.
- the equipment of the present invention consists of a modular production equipment comprising: a) a mixer of gel material capable of mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) an open container with stirring means for cross-linking solution and/or culture media with separation means to remove the cross-linking solution and/or the culture media; c) dropping means located above the open container capable of supplying drops of the cell-gel mixture.
- the equipment and process of the present invention allow obtaining edible spherical tissue clusters as culture meat product.
- Fig. 1 shows metabolic activity through 14 days of culture on three different scaffolds: filled fibers, hollow fibers and hollow spheres, which were embedded with C2C12 cells.
- Fig. 2 shows metabolic activity through 14 days of culture on two different scaffolds: hollow fibers and hollow spheres, which were embedded with porcine satellite cells (pSC).
- Fig. 3 shows cell proliferation per area unit through 14 days of culture within three different scaffolds: filled fibers, hollow fibers and hollow spheres, which were embedded with C2C12 cells.
- Fig. 4 shows cell proliferation per area unit through 14 days of culture within two different scaffolds: hollow fibers and hollow spheres, which were embedded with porcine satellite cells (pSC).
- pSC porcine satellite cells
- Fig. 5 shows cell doubling per area unit on three different scaffolds: filled fibers, hollow fibers and hollow spheres, which were embedded with C2C12 cells, wherein the cell doubling data was obtained through final comparison on cell numbers at the peak of the culture and initial cell numbers within the scaffolds.
- Fig. 6 shows cell doubling per area unit on two different scaffolds: hollow fibers and hollow spheres, which were embedded with porcine satellite cells (pSC), wherein the cell doubling data was obtained through final comparison on cell numbers at the peak of the culture and initial cell numbers within the scaffolds.
- pSC porcine satellite cells
- a cultured meat production process comprising the steps of: a) mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) letting the cell-gel mixture drop into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross-linkable material; c) cross-linking the cell-gel mixture by keeping a suspension of cell-gel mixture droplets in the crosslinking solution until cross-linking is achieved thereby obtaining spherical cell-loaded edible scaffolds; d) removing the cross-linking solution with the non-cross-linkable gel material; e) growing the cells in the cell-loaded edible scaffolds in culture media; and f) removing the culture media to obtain tissue spheres.
- the cell-gel mixture is preferably of the type generally considered a bio-ink as it comprises a gel material and a live component.
- the cells loaded in the into de cross-linkable edible gel material are suitable for meat culture, preferably selected from myoblasts, myocytes, adipocytes, fibroblasts, satellite cells and any stem cells capable of differentiating into muscular or adipose tissue.
- the cells are selected from animals susceptible of human or animal consumption, preferably selected from mammals, birds, fish and shellfish. More preferably, the cells are capable of developing into animal muscular or adipose tissue selected from fish, crustacean, mouse, bovine, cattle, swine and poultry.
- the cross-linkable edible gel material comprises an organic polymer able to provide firmness to the scaffold and anchorable sites for cell adhesion, more preferably a polysaccharide, protein, peptide or a combination thereof; a cross-linkable hydrogel, preferably a photo-cross-linkable hydrogel; a cell-proliferation stimulant; and, a buffer solution, preferably phosphate based.
- the organic polymers are selected from alginate, hyaluronic acid, agarose, gelatin, collagen or a combination thereof.
- the polymer preferably has such flow properties to allow its lamellar flow through the mixer.
- the mixer comprises two inlets to properly mix components, and therefore the selected hydrogels preferably have similar viscosity to enable equal lamellar flow and proper internal microstructure formation.
- the polymer and hydrogel rheology values of the present invention shall not be limited but by the nature of the cells that will be grown therein, as long as the rheological properties are such that will allow mixing and dropping from the mixer.
- the cross-linkable hydrogel is preferably selected from gelatin methacryloyl, collagen, fibrin, silk, hyaluronic acid, agarose, chitosan, cellulose, alginate, soy, extracellular matrix (ECM, such as but not limited to Matrigel ®), elastin, gelatin, polyethylene glycol (PEG), polyprolylene fumarate - polyethylene glycol (PPF-PEG), polyethylene oxide (PEO), polylactic acid (PLA), polyglycolic acid (PGA), polyethylene glycol diacrylate (PEGDA), and functionalized versions thereof, and it is further preferred to use gelatin methacryloyl.
- ECM extracellular matrix
- PEG polyethylene glycol
- PPF-PEG polyprolylene fumarate - polyethylene glycol
- PEO polyethylene oxide
- PLA polylactic acid
- PGA polyglycolic acid
- PEGDA polyethylene glycol diacrylate
- hydrogel cross-linking agent calcium ions can be used for polymers such as alginate, preferably in the form of a calcium chloride solution.
- hydrogel is photo-cross- linkable, such as gelatin metacryloyl, it is preferred using a photocrosslinker/initiator such as Irgacure®, or Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) together with UV light, more preferably LAP with UV light.
- photocrosslinker/initiator such as Irgacure®, or Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP)
- the buffer solution is selected from Dulbecco’s Phosphate Buffered Saline (DPBS), phosphate buffered saline (PBS), sodium phosphate, tris(hydroxymethyl)aminomethane buffer (Tris), Hank's balanced salt solution (HBSS), 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES) buffer, Sodium bicarbonate, Ethylenediaminetetraacetic acid (EDTA) buffer, and mineral buffers, and more preferably it is used Dulbecco's Phosphate Buffered Saline (DPBS).
- DPBS Dulbecco's Phosphate Buffered Saline
- DPBS Dulbecco's Phosphate Buffered Saline
- the proportions of the components of the cross-linkable edible gel material are adjusted according to the quantity and type of cells to be seeded therein, and according to the nature of such components, but in a preferred embodiment, the organic polymer is added in 2 to 3% w/v, preferably 2% w/v; and the hydrogel is added in an amount of 0.1% to 3% w/v, preferably 3% w/v.
- the loading of cells into the cross-linkable edible gel material is made by simply adding the material to the cells, preferably in darkness conditions in the embodiment where the material is set for photo-cross-linking.
- the count of cells to load is set according to the growth rate of the cells and on the application and type of cell used. Usually, cells require proximity to other cells for successful communication in order to perform desired functions such as proliferation or differentiation.
- the minimum load of cells is O.lxlO 6 cells/mL of cross-linkable edible gel material, and more preferably of at least 3xl0 6 cells/mL of cross-linkable edible gel material.
- Upper limits for cell concentrations are defined by the minimum concentration of polymers in the solution to still be able to perform the cross-linking into a stable hydrogel.
- the term edible refers to the fact that the material can be generally safely eaten by a healthy people or mammals, that is, without affecting their health condition.
- the second non-cross-linkable gel material comprises an innocuous water- soluble polymer enabling the formation of hollow structures within the scaffold for enhanced nutrient perfusion upon removal, preferably selected from cellulose derivatives.
- the non-cross-linkable gel material is hydroxyethyl cellulose (HEC), or any other polymer that has similar rheological properties and does not cross-link with the mechanism used for crosslinking the stable hydrogel, such as Poloxamer 407.
- innocuous refers to the fact that the material or traces thereof do not affect the health condition of healthy people or mammals if ingested.
- the mixing step of the first cell-loaded cross-linkable edible gel material with the second non-cross-linkable gel material to obtain the cell-gel mixture is performed through any technique known in the art for bio-inks in bioprinting processes, for example those described by Ravanbakhsh, H., Karamzadeh, V., Bao, G., Mongeau, L., Juncker, D., Zhang, Y. S., Emerging Technologies in Multi-Material Bioprinting. Adv. Mater. 2021, 33, 2104730; or by Zhang, Y. S., Oklu, R., Dokmeci, M. R., & Khademhosseini, A. (2018). Three-Dimensional Bioprinting Strategies for Tissue Engineering.
- a plurality of mixers and/or mixture delivery fixtures are configured in parallel so that a plurality of droplets with a minimum diameter of 1 mm, preferably of a diameter of 3 mm, is produced, in order to maximize the flow of cell-gel droplets thereby obtained for mass production.
- the drops thereby obtained are let drop into a container with the solution for crosslinking, wherein the solution comprises an alkaline or alkaline earth metal cross-linker, such as calcium ions, preferably calcium chloride (CaCh) and water.
- the solution comprises an alkaline or alkaline earth metal cross-linker, such as calcium ions, preferably calcium chloride (CaCh) and water.
- such solution dissolves the second non-cross-linkable material in the cell-gel droplets, in order obtain spherical cell-loaded edible scaffolds which have only the cross-linked material as a structure with the embedded cells therein.
- the cross- linking/dissolution process preferably lasts around 1 to 2 minutes, preferably 2 minutes.
- the cross-linking solution is then removed from the container along with the non-cross- linkable gel material dissolved therein, while the cell-loaded edible scaffolds are transferred into a culture vessel or bioreactor for cell growth in a culture media.
- bioreactors may be used under the principles of the present invention because the spherical cell-loaded edible scaffolds obtained by the process of the present invention do not require special configurations to keep fibers untangled or with a determined shape for growth, unlike the scaffolds obtained in the prior art.
- the bioreactor where the cell culture is performed under the principles of the present invention are non-restricted. Active processes, such as those employed by standard stirred tank or rocker reactors, as well as passive, static culturing can be utilized. Reactors at a minimum must provide a sterile environment, temperature controlled between 32°C to 40°C, preferably 37°C, and exist at a minimum of approximately 1 atmosphere of pressure.
- the cell growth step is preferably performed in a culture media suitable for the cells to be grown and is performed at a temperature and during a time according to the kinetics of the growth of such cells.
- the cell growth step will be performed at 37°C, for at least 48 hours, preferably under inert atmosphere.
- Preferred culture media is selected according to the conditions required for the growth of the cells in the cell-loaded edible scaffold to be processed and any suitable basal culture medium well known in the art can be used, but in a preferred embodiment, there is used Dulbecco's Modified Eagle's Medium - high glucose (DMEM-hg) supplemented with 10% Fetal Bovine Serum and 1% Anti-Anti (Penicillin 10,000 units/mL - Streptomycin 10,000 pg/mL- 25 pg/mL of amphotericin B).
- DMEM-hg Dulbecco's Modified Eagle's Medium - high glucose
- Anti-Anti Penicillin 10,000 units/mL - Streptomycin 10,000 pg/mL- 25 pg/mL of amphotericin B.
- natural origin compounds are preferred, more particularly curcumin, gingerol, dehydrocorydaline (from Corydalis tuber), tetrahydropalmatine (from Corydalis turtschaninovii), (-)- epicatechin gallate and (— )-epigallocatechin-3-gallate (from green tea).
- induction can begin by addition of surface receptor ligands, by using insulin+LPA+transferrin, by formulating differentiation medium fusing neurobasal + Leibovitz's - 15 medium (L15) + Insulin- like Growth Factor (IGF) + Epidermal Growth Factor (EGF), or by increasing the net, overall scaffold stiffness.
- IGF Insulin- like Growth Factor
- EGF Epidermal Growth Factor
- the cell-loaded edible scaffolds obtained by the process of the invention thereby obtained have preferably a diameter bigger than 1 mm, preferably 3 mm, which allows cells to grow within the scaffold and not only on the surface, thereby maximizing nutrient availability and therefore cell growth.
- Another aspect of the invention comprises a cell-loaded edible scaffold having a substantially spherical shape of a diameter bigger than 1 mm, preferably 3mm, and comprising a cell-gel mixture made of a first cell-loaded cross-linkable edible gel material and a second non-cross-linkable gel material wherein the cell-loaded scaffold is capable of dissolving into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross- linkable material.
- the equipment of the present invention consists of a modular production equipment comprising: a) a mixer of gel material capable of mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) an open container for cross-linking solution and/or culture media with separation means to remove the cross-linking solution and/or the culture media; c) dropping means located above the open container capable of supplying drops of the cell-gel mixture.
- the mixer may be of the type generally known in the art of bioprinting, but must comprise mixture delivery fixtures allowing low flow rates enough to achieve dropping of the mixed cell-gel.
- the mixer comprises an extrusion equipment further equipped with a head or dice for allowing droplets to fall.
- the mixer may be selected from any commercially available capable of handling the first cell-loaded cross-linkable edible gel material and the second non-cross-linkable gel material according to their rheological properties, including but not limited to motionless static mixers.
- a plurality of mixers and/or mixture delivery fixtures are configured in parallel so that a plurality of droplets from 1 mm of diameter, preferably 3 mm, is produced in order to maximize the flow of cell-gel droplets thereby obtained for mass production in a single open container.
- the separation means of the open container are selected between sieves and valves configured to enable the cell-gel or the meat-like tissue spheres to be kept into the container while the solution or the cell culture is removed.
- the equipment and process of the present invention allow obtaining edible substantially spherical tissue clusters as cultured meat product.
- the spherical tissue clusters of the present invention comprise the remaining edible cross-linked gel material as described and a meat tissue formed from the cultured cells, in both the surface and the inner body of the spheres.
- the present disclosure also refers to a muscular and/or adipose tissue particle comprising a cross-linked edible gel material that is substantially spherical, with a diameter bigger than 1 mm, and at least 100,000 cells per cross-linked edible gel material outer surface area unit.
- Example 1A Cell-loaded cross-linkable edible gel material
- Low viscosity alginate (LVA) was dissolved in Dulbecco's phosphate-buffered saline (DPBS) in a proportion of 2% w/v to which gelatin methacryloyl in 3% w/v and 0.3% w/v of LAP were also added.
- DPBS Dulbecco's phosphate-buffered saline
- the mixture was heated to 70°C for 15 minutes and then sterilized through filtration with syringe filters and then tempered to 37°C for addition of 3xl0 6 cells/mL of either immortalized mouse myoblast cell line ATCC Number CRL-1772 or a primary culture of porcine muscle satellite cells which are multipotent stem cells, thereby obtaining the cell-loaded cross-linkable edible material.
- Example IB Cross-linkable edible gel material (non cell-loaded) Low viscosity alginate (LVA) was dissolved in Dulbecco's phosphate-buffered saline (DPBS) in a proportion of 2% w/v to which gelatin methacryloyl in 3% w/v and 0.3% w/v of LAP were also added. The mixture was heated to 70°C for 15 minutes and then sterilized through filtration with syringe filters and then tempered to 37°C, thereby obtaining a cross-linkable edible material without cells loaded as used in the prior art.
- DPBS Dulbecco's phosphate-buffered saline
- HEC Hydroxyethyl cellulose
- Example 1 A or B
- a second scaffolding material including the material of Example 2 in some cases, and further obtaining either fibers or droplets to be cross-linked in a solution of 2% w/v CaCI2 in DPBS.
- the materials to be shaped as fibers 5 mL of the mixed materials were extruded inside the cross-linking CaCh solution at a rate of 1.5 mL/min to avoid tangling or misshaping of the obtained fibers.
- the fibers thereby obtained were then taken out from the solution, and carefully organized and placed on petri dishes to be subject to UV light for 30 seconds for cross-linking and then placed in ultra-low adherence plates (Costar® 24 well plates Cat. Id 3473) for cell culture.
- the materials shaped as droplets were processed similarly, but instead of extruding them directly into the cross-linking CaCh solution, they were simply let drop from above the solution container at a rate of 1.5 mL/min.
- the spheres obtained from the droplets were recovered and cross-linked at the same conditions than fibers, except that no measures were taken to handle or order the spheres.
- the obtained fibers or spheres were then incubated in Dulbecco's Modified Eagle's Medium - high glucose (DMEM-hg) supplemented with 10% Fetal Bovine Serum and 1% Anti-Anti (Penicillin 10,000 units/mL - Streptomycin 10,000 pg/mL- 25 pg/mL of amphotericin B) at 37°C under an atmosphere of 5% of carbon dioxide.
- DMEM-hg Dulbecco's Modified Eagle's Medium - high glucose
- Anti-Anti Penicillin 10,000 units/mL - Streptomycin 10,000 pg/mL- 25 pg/mL of amphotericin B
- the culture was performed for 14 days and cell viability was assessed with Presto Blue Assay in days 4, 7, 10, and 14.
- Cell count (CC) and doublings (CD) were assessed with CyQUANT assay on the same days under the following formula:
- metabolic activity was measured through PrestoBlue® cell viability kit on day 1, 4, 7, 10 and 14, setting day 1 as reference point of comparison.
- the results for Examples 3A to 3D are shown in Fig. 1, and the results for Examples 3E and 3F are shown in Fig. 2.
- cell proliferation within the scaffolds was measured by using CyQUANT® cell proliferation kit as explained before.
- the area of scaffolds was measured according to the following: a) for fibers, the area was calculated with the formula to calculate the total surface area of the cylinder: 2nrh-;-2nr 2 , and considering that the diameter of each sample is 0.15 cm and the height is 2 cm; and b) for spheres, the surface area was calculated with the formula: 4nr 2 , and considering a diameter of 0.4 cm. From this, it was found that fibers surface area measures 0.98 cm 2 while spheres surface area is 0.5 cm 2 . Thus, the cell number per area unit (cm 2 ) was calculated for each example.
- the results for Examples 3A to 3D are shown in Fig. 3, and the results for Examples 3E and 3F are shown in Fig. 4.
- FIG. 3 shows immortalized mouse myoblast C2C12 (Fig. 3) and primary culture of porcine Satellite cells (pSC) (Fig. 4).
- Fig. 3 shows cell growth through a 14-day incubation period, and for both cell types, best cell growth can be observed on hollow spheres scaffolds, under static conditions.
- C2C12 cells growth reached its peak on day 10 of culture when the scaffold was a sphere, and on day 14 when the scaffold was a fiber, while for pSC, the cell growth was reached on day 14 for both fibers and spheres. It is important to notice the difference of cell number within day 1 which varies according to the cell type and scaffold.
- C2C12 being an immortalized cell line grows faster than primary cell culture of pSC. Additionally, the area of the fibers being analyzed is 2 to 3.5 times greater than spheres.
- cell doubling within the scaffolds was measured through a comparison on cell numbers at the peak of the culture and initial cell numbers within the scaffolds.
- the results of cell doubling per area unit (cm 2 ) obtained for scaffolds loaded with C2C12 cells are shown in Fig. 5 and the results obtained for pSC are shown in Fig. 6.
- hollow spheres scaffolds were embedded with C2C12 at a density of 3 million cells per mL of cell ink. Scaffolds were later incubated in a Spinner Flask at 50 rpm for two weeks. At day 14 samples were stained with fluorescent markers for cell viability (Live-Dead) and fixed for immunofluorescence staining of Actin -DAPI. 2.5X scale bar: 500 pm, 10X scale bar: 100 pm.
- samples corresponding to day 14 of hollow spheres scaffolds embedded with C2C12 cells at a density of 3 million cells per mL of cell ink and incubated on Spinner Flask at 50 rpm for two weeks were stained with fluorescent markers for cell viability (Live-Dead) and fixed for immunofluorescence staining of Actin- DAPI, observing high cell viability on hollow spheres scaffolds even after being subjected to 50 rpm throughout the whole two weeks of incubation (data not shown).
- C2C12 differentiation was observed by cells arrangement through their Actin filaments stained by red dye whereas nuclei are seen by blue DAPI staining (not shown in figures).
- Example 4 Process-ability of spheres and fibers.
- different processing flows were compared for fibers and spheres at different rates.
- Live-Dead staining as explained above was made instantly after extrusion to verify cell viability post-extrusion (day 0). The results were as follows:
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A cultured meat production process comprising the steps of: a) mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) letting the cell-gel mixture drop into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross-linkable material; c) cross-linking the cell-gel mixture by keeping a suspension of cell-gel mixture droplets in the cross-linking solution until cross-linking is achieved thereby obtaining spherical cell-loaded edible scaffolds; d) removing the cross-linking solution with the non-cross-linkable gel material; e) growing the cells in the cell-loaded edible scaffolds in culture media; and f) removing the culture media to obtain tissue spheres, is provided. The invention further provides a cell-loaded edible scaffold and an equipment for enabling a cultured meat production process, as well as a muscular and/or adipose tissue particle and a meat product comprising said particles.
Description
CULTURED MEAT PRODUCTION PROCESS, MATERIALS AND EQUIPMENT
FIELD OF THE INVENTION
The invention pertains to the field of food production and tissue engineering and particularly refers to the production of meat by cell culture and the equipment required to implement the same.
BACKGROUND OF THE INVENTION
Meat culture has been developed over the years as an alternative to animal sacrifices by establishing processes that enable the growth of muscular tissue from stem cells that grow on structures or patterns so-called scaffolds that allow the adhesion of the differentiated cells and its growth to form tissue that is similar to the tissue of meat obtained from sacrificed animals, a process that corresponds to the field known as tissue engineering.
The current techniques of tissue engineering, however, have been developed mainly to enable tissue restoration for medical applications, the majority of which lead to a scaffold that has cells, embedded or adhered, capable of differentiating to the target tissue, such as bone, cartilage or organs such as kidney, liver, nerves, heart muscle or pancreas among others.
However, the nature of such techniques is not built for large scale production of tissues as needed by the meat industry, and therefore, the techniques are not suitable for the production of cultured meat for a variety of reasons, including edibility of the scaffolds or production rate and form of the scaffolds/tissue.
For instance, there has been described generally that the ability of the scaffolding material to receive cells within the material. That is the case of the scaffolds described in publication W02013/050921, where hollow microspheres are seeded with cells which are then used for detecting cancer by exposure to a test specimen. These microspheres cannot be applied to meat culture because they contain glass and are inedible.
Furthermore, in general, for the current techniques there is a need to have a process where the tissue is implanted into a person or an animal in order to continue the evolution of the cell growth in order to achieve the desired result, or in the case of the efforts to build full organs, the need to have very specific shapes and order for the growth of the cells in order to conform an organ-like structure.
For instance, a tissue that is often consumed as a kind of meat, liver tissue generation is of interest, such as the case of publication number JP2017085945. Although the document focuses in achieving liver function, it describes three-dimensional culturing of cells by inoculating a biodegradable scaffold material with a hepatocyte, and endothelial cell and a mesenchymal stem cell, and the culturing them therein under a simulated microgravity environment, which is also very complex to get for large scale production of meat.
As observed, 3D scaffold printing is one of the most used techniques in tissue engineering, which includes typically the need to prepare an ink with proper materials through a mixing equipment and then extruding it onto a surface or a liquid to conform scaffolds or structures that will be used, once formed, to grow the cells of interest therein. Under these conditions cells are adhered to the outer surface of the scaffolds and even in porous materials they will not take advantage of the whole available holes or hollow spaces within the scaffold.
Accordingly, despite the large number of technologies developed in the field of tissue engineering and the advances in the techniques related thereto, technologies suitable for producing large volumes of tissue as necessary for the food industry are still insufficiently developed and scarce.
Amongst the few technologies that have been developed as an effort to increase the production volumes of meat cultures, it is found publication number W02021/250290 related to a method for the synthesis of a three dimensional porous, edible and sterilizable matrix for the production of cultured meat in large scale. The matrix described therein is made of biocompatible polymers with pores interconnected as a support material for the growth, proliferation and differentiation of adherent cells, which may be used to obtained tissue with nurturing content and/or cultivated meat. The biopolymer used therein as a scaffold may be sterilizable with steam and may be eaten by a person. Such scaffold is produced by depositing a drop of a polymer solution on a chilled surface, which will make it freeze into semi-spherical scaffold particles, which are then dried through lyophilization for use in a further process where the cells are put in contact with the so obtained scaffolds for obtaining the cultured meat. This process has several disadvantages for scaling up, including the use of lyophilization and the need to use equipment for cooling the bed where the biopolymer is dropped on, which makes it expensive, and it keeps the need to embed the scaffold with the cells for growth in a further processing step and limits the growth of the cells as these are typically adhered predominantly to the surface of the scaffold.
As shown here, the edibility of the scaffolding material is one of the targets to achieve, and there are other scaffolds in the prior art that are biocompatible and might be edible, such as that described in publication CN106110402 where cells for human skin are constructed within a sodium alginate hydrogel scaffold and then grown in a layer structure as sheets for application to wounds.
From the bio-ink perspective, another applicable technique may be that described in publication CN101904775B, that describes a tissue-like manufacture die based on spheroid elementary unit and preparation process, which does not describe an application to meat culture but does refer to different applications as it uses a molding die for extrusion (die and press) in order to perform a forming operation based on an ink that comprises globules that are first formed and then grown to bigger cell clusters that will be in turn implanted. A bio-ink in this context is understood as a mixture of components that in addition to the scaffolding materials as described before, also includes a biological material before it is otherwise formed so that it is possible to provide a pattern for growth with the cells embedded therein.
Another approach to obtain hollow scaffolds and bio-inks has been also described in document published as W02021/062411. The methods described therein comprise providing a bio-ink composition and a fugitive ink composition followed by a chaotic printing process to generate a micro-
structured precursor comprising a plurality of lamellar structures formed from the bio-ink composition in order to obtain fiber/filament shapes. The bio-ink composition is then cured to form a scaffold precursor and finally the fugitive ink is removed from the cured scaffold precursor, thereby forming a perfusable fiber-shaped scaffold. The difference of this procedure as compared to other procedures previously referred to, such as that of W02021/250290, is that the document describes the possibility of dispersing a population of cells in the bio-ink composition prior to the chaotic printing of the filament or fiber shape. However, the procedure described therein requires a careful control of the flow of the bio-ink and fugitive ink compositions through the process in order to achieve the laminar flow necessary to form the lamellar interfaces between the bio-ink and the fugitive ink, which in turn is achieved by co-extrusion of both inks under such controlled flow conditions. Such controlled conditions must remain throughout the filament/fiber formation process, as such fibers can be entangled as they become longer. Therefore, this technique is also very difficult to use in meat culture since the flow control required is a burden to obtain large volumes of the scaffold faster, even if the cells are diffused prior to the bioprinting process through extrusion. Furthermore, the same document describes a complex bioreactor structure for the scaffolds thereby obtained, which prevents the possibility of obtaining a high volume of meat as a result, as the lamellar materials thereby obtained require careful handling to keep its integrity after extrusion, and do not resist shear stresses for more efficient culture processes requiring mixing.
Another problem that prior art processes have not solved is the ability of cells to be fed from the culture media, which leads to a high rate of cell loss when scaffolds are thicker than 200 microns.
Given the current state of development of the technologies, cultured meat is still extremely expensive and viable only in small-scale processing, because the current technologies cannot be enabled in larger equipment to maximize the volume of tissue thereby obtained.
OBJECTIVES OF THE INVENTION
Considering the drawbacks and problems of the technologies related to tissue engineering that prevent them to be applied to meat culture in larger scales, it is an object of the present invention to provide a process for meat culture that is not dependent on a forming process such as die casting or extrusion.
It is another object of the present invention to provide a process for meat culture that is not dependent on a strict control of the flow rate of bio-inks or fugitive inks.
It is yet another object of the present invention to provide a process for meat culture that does not need forming a scaffold and cell embedding as sequential steps.
It an additional object of the present invention to provide a scaffold that allows cells to grow within the scaffold and not only on the surfaces that increase the shear stress resistance of the culture during cell growth.
It is a further object of the present invention to provide a scaffold that allows cell nutrients to penetrate within the scaffold to reduce cell death.
It is an additional object of the present invention to provide equipment for enabling the process for meat culture of the present invention at large scale.
These and other objects are achieved through the cultured meat production process and equipment of the present invention.
BRIEF DESCRIPTION OF THE INVENTION
Under the principles of the present invention, it is provided a cultured meat production process comprising the steps of: a) mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) letting the cell-gel mixture drop into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross-linkable material; c) cross-linking the cell-gel mixture by keeping a suspension of cell-gel mixture droplets in the crosslinking solution until cross-linking is achieved thereby obtaining spherical cell-loaded edible scaffolds; d) removing the cross-linking solution with the non-cross-linkable gel material; e) growing the cells in the cell-loaded edible scaffolds in culture media; and f) removing the culture media to obtain tissue spheres.
The cell-loaded edible scaffolds obtained by the process of the invention thereby obtained have preferably a diameter bigger than 3 mm which allows cells to grow within the scaffold and not only on the surface, thereby maximizing nutrient availability and therefore cell growth.
The equipment of the present invention consists of a modular production equipment comprising: a) a mixer of gel material capable of mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) an open container with stirring means for cross-linking solution and/or culture media with separation means to remove the cross-linking solution and/or the culture media; c) dropping means located above the open container capable of supplying drops of the cell-gel mixture. Finally, the equipment and process of the present invention allow obtaining edible spherical tissue clusters as culture meat product.
BRIEF DESCRIPTION OF THE DRAWINGS
The novel and unique aspects of the invention shall be specified in the appended claims. However, some embodiments, features and advantages of the same shall be better understood in connection with the detailed description when read in relation to the appended figures, wherei Fig. 1 shows metabolic activity through 14 days of culture on three different scaffolds: filled fibers, hollow fibers and hollow spheres, which were embedded with C2C12 cells.
Fig. 2 shows metabolic activity through 14 days of culture on two different scaffolds: hollow fibers and hollow spheres, which were embedded with porcine satellite cells (pSC).
Fig. 3 shows cell proliferation per area unit through 14 days of culture within three different scaffolds: filled fibers, hollow fibers and hollow spheres, which were embedded with C2C12 cells.
Fig. 4 shows cell proliferation per area unit through 14 days of culture within two different scaffolds: hollow fibers and hollow spheres, which were embedded with porcine satellite cells (pSC).
Fig. 5 shows cell doubling per area unit on three different scaffolds: filled fibers, hollow fibers and hollow spheres, which were embedded with C2C12 cells, wherein the cell doubling data was obtained through final comparison on cell numbers at the peak of the culture and initial cell numbers within the scaffolds.
Fig. 6 shows cell doubling per area unit on two different scaffolds: hollow fibers and hollow spheres, which were embedded with porcine satellite cells (pSC), wherein the cell doubling data was obtained through final comparison on cell numbers at the peak of the culture and initial cell numbers within the scaffolds.
DETAILED DESCRIPTION OF THE INVENTION
Under the principles of the present invention, it is provided a cultured meat production process comprising the steps of: a) mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) letting the cell-gel mixture drop into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross-linkable material; c) cross-linking the cell-gel mixture by keeping a suspension of cell-gel mixture droplets in the crosslinking solution until cross-linking is achieved thereby obtaining spherical cell-loaded edible scaffolds; d) removing the cross-linking solution with the non-cross-linkable gel material; e) growing the cells in the cell-loaded edible scaffolds in culture media; and f) removing the culture media to obtain tissue spheres.
The cell-gel mixture is preferably of the type generally considered a bio-ink as it comprises a gel material and a live component. The cells loaded in the into de cross-linkable edible gel material are suitable for meat culture, preferably selected from myoblasts, myocytes, adipocytes, fibroblasts, satellite cells and any stem cells capable of differentiating into muscular or adipose tissue. In a preferred embodiment, the cells are selected from animals susceptible of human or animal consumption, preferably selected from mammals, birds, fish and shellfish. More preferably, the cells are capable of developing into animal muscular or adipose tissue selected from fish, crustacean, mouse, bovine, cattle, swine and poultry.
The cross-linkable edible gel material comprises an organic polymer able to provide firmness to the scaffold and anchorable sites for cell adhesion, more preferably a polysaccharide, protein, peptide or a combination thereof; a cross-linkable hydrogel, preferably a photo-cross-linkable hydrogel; a cell-proliferation stimulant; and, a buffer solution, preferably phosphate based.
More specifically, the organic polymers are selected from alginate, hyaluronic acid, agarose, gelatin, collagen or a combination thereof. The polymer preferably has such flow properties to
allow its lamellar flow through the mixer. Moreover, in a preferred embodiment, the mixer comprises two inlets to properly mix components, and therefore the selected hydrogels preferably have similar viscosity to enable equal lamellar flow and proper internal microstructure formation. However, the polymer and hydrogel rheology values of the present invention shall not be limited but by the nature of the cells that will be grown therein, as long as the rheological properties are such that will allow mixing and dropping from the mixer.
The cross-linkable hydrogel is preferably selected from gelatin methacryloyl, collagen, fibrin, silk, hyaluronic acid, agarose, chitosan, cellulose, alginate, soy, extracellular matrix (ECM, such as but not limited to Matrigel ®), elastin, gelatin, polyethylene glycol (PEG), polyprolylene fumarate - polyethylene glycol (PPF-PEG), polyethylene oxide (PEO), polylactic acid (PLA), polyglycolic acid (PGA), polyethylene glycol diacrylate (PEGDA), and functionalized versions thereof, and it is further preferred to use gelatin methacryloyl.
Finally, regarding the hydrogel cross-linking agent, calcium ions can be used for polymers such as alginate, preferably in the form of a calcium chloride solution. When the hydrogel is photo-cross- linkable, such as gelatin metacryloyl, it is preferred using a photocrosslinker/initiator such as Irgacure®, or Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) together with UV light, more preferably LAP with UV light.
The buffer solution is selected from Dulbecco’s Phosphate Buffered Saline (DPBS), phosphate buffered saline (PBS), sodium phosphate, tris(hydroxymethyl)aminomethane buffer (Tris), Hank's balanced salt solution (HBSS), 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES) buffer, Sodium bicarbonate, Ethylenediaminetetraacetic acid (EDTA) buffer, and mineral buffers, and more preferably it is used Dulbecco's Phosphate Buffered Saline (DPBS).
The proportions of the components of the cross-linkable edible gel material are adjusted according to the quantity and type of cells to be seeded therein, and according to the nature of such components, but in a preferred embodiment, the organic polymer is added in 2 to 3% w/v, preferably 2% w/v; and the hydrogel is added in an amount of 0.1% to 3% w/v, preferably 3% w/v.
The loading of cells into the cross-linkable edible gel material is made by simply adding the material to the cells, preferably in darkness conditions in the embodiment where the material is set for photo-cross-linking. The count of cells to load is set according to the growth rate of the cells and on the application and type of cell used. Mostly, cells require proximity to other cells for successful communication in order to perform desired functions such as proliferation or differentiation. In a preferred embodiment, the minimum load of cells is O.lxlO6 cells/mL of cross-linkable edible gel material, and more preferably of at least 3xl06 cells/mL of cross-linkable edible gel material. Upper limits for cell concentrations are defined by the minimum concentration of polymers in the solution to still be able to perform the cross-linking into a stable hydrogel.
As used here, the term edible refers to the fact that the material can be generally safely eaten by a healthy people or mammals, that is, without affecting their health condition.
Regarding the second non-cross-linkable gel material, it comprises an innocuous water- soluble polymer enabling the formation of hollow structures within the scaffold for enhanced nutrient perfusion upon removal, preferably selected from cellulose derivatives. In a preferred embodiment the non-cross-linkable gel material is hydroxyethyl cellulose (HEC), or any other polymer that has similar rheological properties and does not cross-link with the mechanism used for crosslinking the stable hydrogel, such as Poloxamer 407.
As used here, the term innocuous refers to the fact that the material or traces thereof do not affect the health condition of healthy people or mammals if ingested.
The mixing step of the first cell-loaded cross-linkable edible gel material with the second non-cross-linkable gel material to obtain the cell-gel mixture is performed through any technique known in the art for bio-inks in bioprinting processes, for example those described by Ravanbakhsh, H., Karamzadeh, V., Bao, G., Mongeau, L., Juncker, D., Zhang, Y. S., Emerging Technologies in Multi-Material Bioprinting. Adv. Mater. 2021, 33, 2104730; or by Zhang, Y. S., Oklu, R., Dokmeci, M. R., & Khademhosseini, A. (2018). Three-Dimensional Bioprinting Strategies for Tissue Engineering. Cold Spring Harbor perspectives in medicine, 8(2), a025718, and more preferably is made through mixing equipment and mixture delivery fixtures allowing flow rates enough to achieve dropping of the mixed cell-gel. In a preferred embodiment of the invention, an extrusion equipment equipped with a head or dice for allowing droplets to fall is used.
In a further embodiment of the mixing step, a plurality of mixers and/or mixture delivery fixtures are configured in parallel so that a plurality of droplets with a minimum diameter of 1 mm, preferably of a diameter of 3 mm, is produced, in order to maximize the flow of cell-gel droplets thereby obtained for mass production.
The drops thereby obtained are let drop into a container with the solution for crosslinking, wherein the solution comprises an alkaline or alkaline earth metal cross-linker, such as calcium ions, preferably calcium chloride (CaCh) and water. At the same time, such solution dissolves the second non-cross-linkable material in the cell-gel droplets, in order obtain spherical cell-loaded edible scaffolds which have only the cross-linked material as a structure with the embedded cells therein. The cross- linking/dissolution process preferably lasts around 1 to 2 minutes, preferably 2 minutes.
The cross-linking solution is then removed from the container along with the non-cross- linkable gel material dissolved therein, while the cell-loaded edible scaffolds are transferred into a culture vessel or bioreactor for cell growth in a culture media.
Notably, well-known in the art bioreactors may be used under the principles of the present invention because the spherical cell-loaded edible scaffolds obtained by the process of the present invention do not require special configurations to keep fibers untangled or with a determined shape for growth, unlike the scaffolds obtained in the prior art.
Accordingly, the bioreactor where the cell culture is performed under the principles of the present invention are non-restricted. Active processes, such as those employed by standard stirred tank or rocker reactors, as well as passive, static culturing can be utilized. Reactors at a minimum must provide
a sterile environment, temperature controlled between 32°C to 40°C, preferably 37°C, and exist at a minimum of approximately 1 atmosphere of pressure.
The cell growth step is preferably performed in a culture media suitable for the cells to be grown and is performed at a temperature and during a time according to the kinetics of the growth of such cells. Typically, the cell growth step will be performed at 37°C, for at least 48 hours, preferably under inert atmosphere. Preferred culture media is selected according to the conditions required for the growth of the cells in the cell-loaded edible scaffold to be processed and any suitable basal culture medium well known in the art can be used, but in a preferred embodiment, there is used Dulbecco's Modified Eagle's Medium - high glucose (DMEM-hg) supplemented with 10% Fetal Bovine Serum and 1% Anti-Anti (Penicillin 10,000 units/mL - Streptomycin 10,000 pg/mL- 25 pg/mL of amphotericin B). For induction of a myogenic program, natural origin compounds are preferred, more particularly curcumin, gingerol, dehydrocorydaline (from Corydalis tuber), tetrahydropalmatine (from Corydalis turtschaninovii), (-)- epicatechin gallate and (— )-epigallocatechin-3-gallate (from green tea). Furthermore, induction can begin by addition of surface receptor ligands, by using insulin+LPA+transferrin, by formulating differentiation medium fusing neurobasal + Leibovitz's - 15 medium (L15) + Insulin- like Growth Factor (IGF) + Epidermal Growth Factor (EGF), or by increasing the net, overall scaffold stiffness.
Finally, the culture media is separated in order to obtain meat-like tissue spheres.
According to the described process, in the step of growing the cells in the cell-loaded edible scaffolds in culture media, at least 100,000 cells per scaffold outer surface area unit are obtained. Furthermore, a minimum cell doubling of 2.5 per scaffold outer surface area unit is obtained.The cell- loaded edible scaffolds obtained by the process of the invention thereby obtained have preferably a diameter bigger than 1 mm, preferably 3 mm, which allows cells to grow within the scaffold and not only on the surface, thereby maximizing nutrient availability and therefore cell growth.
Another aspect of the invention comprises a cell-loaded edible scaffold having a substantially spherical shape of a diameter bigger than 1 mm, preferably 3mm, and comprising a cell-gel mixture made of a first cell-loaded cross-linkable edible gel material and a second non-cross-linkable gel material wherein the cell-loaded scaffold is capable of dissolving into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross- linkable material.
The equipment of the present invention consists of a modular production equipment comprising: a) a mixer of gel material capable of mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) an open container for cross-linking solution and/or culture media with separation means to remove the cross-linking solution and/or the culture media; c) dropping means located above the open container capable of supplying drops of the cell-gel mixture.
As mentioned before, the mixer may be of the type generally known in the art of bioprinting, but must comprise mixture delivery fixtures allowing low flow rates enough to achieve
dropping of the mixed cell-gel. In a preferred embodiment of the invention, the mixer comprises an extrusion equipment further equipped with a head or dice for allowing droplets to fall.
The mixer may be selected from any commercially available capable of handling the first cell-loaded cross-linkable edible gel material and the second non-cross-linkable gel material according to their rheological properties, including but not limited to motionless static mixers.
In a further embodiment, a plurality of mixers and/or mixture delivery fixtures are configured in parallel so that a plurality of droplets from 1 mm of diameter, preferably 3 mm, is produced in order to maximize the flow of cell-gel droplets thereby obtained for mass production in a single open container.
The separation means of the open container are selected between sieves and valves configured to enable the cell-gel or the meat-like tissue spheres to be kept into the container while the solution or the cell culture is removed.The equipment and process of the present invention allow obtaining edible substantially spherical tissue clusters as cultured meat product. Unlike the prior art products obtained based on structured fiber-like scaffolds which may include tissue on the surface, the spherical tissue clusters of the present invention comprise the remaining edible cross-linked gel material as described and a meat tissue formed from the cultured cells, in both the surface and the inner body of the spheres.
More specifically, the present disclosure also refers to a muscular and/or adipose tissue particle comprising a cross-linked edible gel material that is substantially spherical, with a diameter bigger than 1 mm, and at least 100,000 cells per cross-linked edible gel material outer surface area unit.
In addition, a meat product made of such muscular and/or adipose tissue particles is also described.
Some specific embodiments that show how the invention can be practiced under the principles described herein and some advantages thereof over the prior art are described in the following examples, which must not be considered as the only possible embodiments of the invention, but only as exemplary of determined embodiments of the invention.
EXAMPLES
Example 1 - Cross-linkable edible gel materials
Example 1A. Cell-loaded cross-linkable edible gel material
Low viscosity alginate (LVA) was dissolved in Dulbecco's phosphate-buffered saline (DPBS) in a proportion of 2% w/v to which gelatin methacryloyl in 3% w/v and 0.3% w/v of LAP were also added. The mixture was heated to 70°C for 15 minutes and then sterilized through filtration with syringe filters and then tempered to 37°C for addition of 3xl06 cells/mL of either immortalized mouse myoblast cell line ATCC Number CRL-1772 or a primary culture of porcine muscle satellite cells which are multipotent stem cells, thereby obtaining the cell-loaded cross-linkable edible material.
Example IB. Cross-linkable edible gel material (non cell-loaded)
Low viscosity alginate (LVA) was dissolved in Dulbecco's phosphate-buffered saline (DPBS) in a proportion of 2% w/v to which gelatin methacryloyl in 3% w/v and 0.3% w/v of LAP were also added. The mixture was heated to 70°C for 15 minutes and then sterilized through filtration with syringe filters and then tempered to 37°C, thereby obtaining a cross-linkable edible material without cells loaded as used in the prior art.
Example 2. Non-cross-linkable gel material
Hydroxyethyl cellulose (HEC) was prepared in DPBS at 0.8% w/v by dissolving powdered HEC under stirring and heating conditions at 70°C until a homogeneous solution was obtained. The mixture remains heated in a water bath at 70°C for lh for sterilization purposes and then tempered to 37°C for mixing with the cell-loaded cross-linkable edible material of Example 1.
Example 3. Scaffolding and cell growth
Based on the materials obtained in Examples 1 and 2 there were designed different experiments in order to compare the performance of the process of the present invention with the techniques of the prior art.
For all the examples a commercially available miniaturized mixer of 5.1-7.7cm length with four Kenic's elements was used to mix the cross-linkable edible gel material of Example 1 (A or B) with a second scaffolding material, including the material of Example 2 in some cases, and further obtaining either fibers or droplets to be cross-linked in a solution of 2% w/v CaCI2 in DPBS.
For the materials to be shaped as fibers, 5 mL of the mixed materials were extruded inside the cross-linking CaCh solution at a rate of 1.5 mL/min to avoid tangling or misshaping of the obtained fibers. The fibers thereby obtained were then taken out from the solution, and carefully organized and placed on petri dishes to be subject to UV light for 30 seconds for cross-linking and then placed in ultra-low adherence plates (Costar® 24 well plates Cat. Id 3473) for cell culture.
In turn, the materials shaped as droplets were processed similarly, but instead of extruding them directly into the cross-linking CaCh solution, they were simply let drop from above the solution container at a rate of 1.5 mL/min. The spheres obtained from the droplets were recovered and cross-linked at the same conditions than fibers, except that no measures were taken to handle or order the spheres.
Additionally, experiments regarding the spheres on a constant agitation environment (Spinner Flask) were made for both cell types: immortalized mouse myoblast C2C12 and primary cell culture of porcine Satellite Cells (pSC). Agitation conditions for the scaffolds were set on 50rpm throughout the 14 days of culture.
The obtained fibers or spheres were then incubated in Dulbecco's Modified Eagle's Medium - high glucose (DMEM-hg) supplemented with 10% Fetal Bovine Serum and 1% Anti-Anti (Penicillin 10,000 units/mL - Streptomycin 10,000 pg/mL- 25 pg/mL of amphotericin B) at 37°C under an atmosphere of 5% of carbon dioxide. The culture was performed for 14 days and cell viability was
assessed with Presto Blue Assay in days 4, 7, 10, and 14. Cell count (CC) and doublings (CD) were assessed with CyQUANT assay on the same days under the following formula:
The different experiments and variables are summarized in Table 1 below.
For all the examples, metabolic activity was measured through PrestoBlue® cell viability kit on day 1, 4, 7, 10 and 14, setting day 1 as reference point of comparison. The results for Examples 3A to 3D are shown in Fig. 1, and the results for Examples 3E and 3F are shown in Fig. 2.
As it can be observed in Fig. 1, on day 10, cells growing on hollow scaffolds (3B, 3C and 3D) had a better metabolic activity than those growing on the filled scaffold (3A). From the cells growing on hollow scaffolds, those that were embedded in sphere scaffolds (3C and 3D) had a higher activity and, surprisingly, the cells corresponding to Example 3D showed the highest metabolic activity, despite of being under agitation conditions at 50 rpm, which was expected to jeopardize such activity.
On the other hand, according to Figure 2, for pSC, it was observed a higher metabolic activity for the cells within the hollow spheres, in comparison with the cells within the hollow fiber, on day 10 of culture thus confirming that with different cells the spheres of the present invention have a better performance than fibers.
In addition, cell proliferation within the scaffolds was measured by using CyQUANT® cell proliferation kit as explained before. The area of scaffolds was measured according to the following: a)
for fibers, the area was calculated with the formula to calculate the total surface area of the cylinder: 2nrh-;-2nr2, and considering that the diameter of each sample is 0.15 cm and the height is 2 cm; and b) for spheres, the surface area was calculated with the formula: 4nr2, and considering a diameter of 0.4 cm. From this, it was found that fibers surface area measures 0.98 cm2 while spheres surface area is 0.5 cm2. Thus, the cell number per area unit (cm2) was calculated for each example. The results for Examples 3A to 3D are shown in Fig. 3, and the results for Examples 3E and 3F are shown in Fig. 4.
Said figures demonstrate growth or cell proliferation on two different cell types respectively: immortalized mouse myoblast C2C12 (Fig. 3) and primary culture of porcine Satellite cells (pSC) (Fig. 4). In this sense, both figures show cell growth through a 14-day incubation period, and for both cell types, best cell growth can be observed on hollow spheres scaffolds, under static conditions. For C2C12 cells, growth reached its peak on day 10 of culture when the scaffold was a sphere, and on day 14 when the scaffold was a fiber, while for pSC, the cell growth was reached on day 14 for both fibers and spheres. It is important to notice the difference of cell number within day 1 which varies according to the cell type and scaffold. In this sense, C2C12 being an immortalized cell line grows faster than primary cell culture of pSC. Additionally, the area of the fibers being analyzed is 2 to 3.5 times greater than spheres.
Likewise, for all the examples, cell doubling within the scaffolds was measured through a comparison on cell numbers at the peak of the culture and initial cell numbers within the scaffolds. The results of cell doubling per area unit (cm2) obtained for scaffolds loaded with C2C12 cells are shown in Fig. 5 and the results obtained for pSC are shown in Fig. 6.
According to these figures, best doubling outcomes can be observed on hollow spheres scaffolds, under static conditions, in both cell types being studied.
As for cell viability, hollow spheres scaffolds were embedded with C2C12 at a density of 3 million cells per mL of cell ink. Scaffolds were later incubated in a Spinner Flask at 50 rpm for two weeks. At day 14 samples were stained with fluorescent markers for cell viability (Live-Dead) and fixed for immunofluorescence staining of Actin -DAPI. 2.5X scale bar: 500 pm, 10X scale bar: 100 pm. In order to prove that the scaffolds of the instant invention reduce cell death through cell nutrients penetration, samples corresponding to day 14 of hollow spheres scaffolds embedded with C2C12 cells at a density of 3 million cells per mL of cell ink and incubated on Spinner Flask at 50 rpm for two weeks, were stained with fluorescent markers for cell viability (Live-Dead) and fixed for immunofluorescence staining of Actin- DAPI, observing high cell viability on hollow spheres scaffolds even after being subjected to 50 rpm throughout the whole two weeks of incubation (data not shown). Moreover, C2C12 differentiation was observed by cells arrangement through their Actin filaments stained by red dye whereas nuclei are seen by blue DAPI staining (not shown in figures).
Example 4. Process-ability of spheres and fibers.
For the materials of examples 3B and 3C, different processing flows were compared for fibers and spheres at different rates. In addition, Live-Dead staining as explained above was made instantly after extrusion to verify cell viability post-extrusion (day 0). The results were as follows:
S=successful; F=fragile post-extrusion with low survival time; N=not processable; H=Processable but heterogeneous sizes
These results demonstrate the absence of strict flow rate parameters through the extrusion process in the present invention as opposed to the strict flow control and handling required for fibers. Table 2 provides a detailed description of hollow scaffold achievement where fibers extruded at 2 mL/min or higher are extremely fragile and thus do not survive longer incubation periods. In contrast, spheres do maintain their shape and viability through normal incubation periods and viability through fluorescence microscopy can be seen easily at day 7.
According to what has been described, it shall be observed that the process and equipment of the present invention has been designed to overcome the scalability problems of the prior art by providing a process that can be implemented in large scale in high volume tanks without the need of flow control or scaffold special handling conditions, and it shall be evident to anyone skilled in the art that the embodiments described and illustrated in the examples are only illustrative but do not limit the applicability of the teachings of the description, as there are possible numerous changes in its details within the scope of this description, such as the cell, scaffolding, solution and culture materials.
Therefore, the present invention should not be considered restricted except as required by the prior art or the scope of the appended claims.
Claims
1. A cultured meat production process comprising the steps of: a) mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) letting the cell-gel mixture drop into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cell-gel mixture and of dissolving the second non-cross-linkable material; c) cross-linking the cell-gel mixture by keeping a suspension of cell-gel mixture droplets in the crosslinking solution until cross-linking is achieved thereby obtaining spherical cell-loaded edible scaffolds; d) removing the cross-linking solution with the non-cross-linkable gel material; e) growing the cells in the cell-loaded edible scaffolds in culture media; and f) removing the culture media to obtain tissue spheres.
2. The process according to claim 1, wherein the cells loaded into de cross-linkable edible gel material are selected from myoblasts, myocytes, adipocytes, fibroblasts, satellite cells and any stem cells capable of differentiating into muscular or adipose tissue.
3. The process according to claim 2, wherein the cells are selected from animals susceptible of human or animal consumption, preferably selected from mammals, birds, fish and shellfish.
4. The process according to claim 3, wherein the cells are capable of developing into animal muscular or adipose tissue selected from fish, crustacean, mouse, bovine, cattle, swine and poultry.
5. The process according to claim 1, wherein the cross-linkable edible gel material comprises: 2 to 3% w/v of an organic polymer able to provide firmness to the scaffold and anchorable sites for cell adhesion; 0.1% to 3% w/v of a cross-linkable hydrogel; and, a buffer solution.
6. The process according to claim 5, wherein the organic polymer is a polysaccharide, protein, peptide or a combination thereof.
7. The process according to claim 6, wherein the organic polymer is selected from alginate, hyaluronic acid, agarose, gelatin, collagen or a combination thereof.
8. The process according to claim 5, wherein the cross-linkable hydrogel is a photo-cross- linkable hydrogel.
9. The process according to claim 5, wherein the cross-linkable hydrogel is selected from gelatin methacryloyl, collagen, fibrin, silk, hyaluronic acid, agarose, chitosan, cellulose, alginate, soy, extracellular matrix (ECM), elastin, gelatin, polyethylene glycol (PEG), polyprolylene fumarate - polyethylene glycol (PPF-PEG), polyethylene oxide (PEO), polylactic acid (PLA), polyglycolic acid (PGA), polyethylene glycol diacrylate (PEGDA), and functionalized versions thereof.
10. The process according to claim 9, wherein the cross-linkable hydrogel is gelatin methacryloyl.
11. The process according to claim 5, wherein the buffer is phosphate based.
12. The process according to claim 5, wherein the buffer is selected from Dulbecco’s Phosphate Buffered Saline (DPBS), phosphate buffered saline (PBS), sodium phosphate,
tris(hydroxymethyl)aminomethane buffer (Tris), Hank's balanced salt solution (HBSS), 4-(2- hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES) buffer, Sodium bicarbonate, Ethylenediaminetetraacetic acid (EDTA) buffer, and mineral buffers.
13. The process according to claim 5, wherein the polymer and the hydrogel have similar viscosity to enable equal lamellar flow and proper internal microstructure formation.
14. The process according to claim 1, wherein the minimum load of cells is O.lxlO6 cells/mL of cross-linkable edible gel material.
15. The process according to claim 1, wherein the non-cross-linkable gel material comprises an innocuous water-soluble polymer.
16. The process according to claim 15, wherein the non-cross-linkable gel material is selected from cellulose derivatives.
17. The process according to claim 1, wherein the non-cross-linkable gel material is hydroxyethyl cellulose (HEC) or any other polymer with similar rheological properties and which does not cross-link with the mechanism used for crosslinking the stable hydrogel.
18. The process according to claim 1, wherein step a) is made through mixing equipment and mixture delivery fixtures allowing flow rates enough to achieve dropping of the mixed cell-gel.
19. The process according to claim 18, wherein step a) is made through an extrusion equipment equipped with a head or dice for allowing droplets to fall.
20. The process according to claim 18, wherein a plurality of mixers and/or mixture delivery fixtures are configured in parallel.
21. The process according to claim 1, wherein the droplets have a minimum diameter of 1 mm.
22. The process according to claim 1, wherein the cross-linking solution comprises an alkaline or alkaline earth metal cross-linker.
23. The process according to claim 22, wherein the cross-linking solution comprises calcium ions, preferably calcium chloride (CaCh) and water.
24. The process according to claim 1, wherein the cross-linking/dissolution lasts from 1 to 2 minutes.
25. The process according to claim 1, wherein step e) comprises transferring the cell- loaded edible scaffolds into a culture vessel or bioreactor for cell growth in a culture media.
26. The process according to claim 1, wherein in step e), at least 100,000 cells per scaffold outer surface area unit are obtained.
27. The process according to claim 1, wherein in step e), a minimum cell doubling of 2.5 per scaffold outer surface area unit is obtained.
28. A cell-loaded edible scaffold having a substantially spherical shape of a diameter bigger than 1 mm and comprising a cell-gel mixture made of a first cell-loaded cross-linkable edible gel material and a second non-cross-linkable gel material wherein the cell-loaded scaffold is capable of
dissolving into a cross-linking solution capable of cross-linking the cross-linkable gel material in the cellgel mixture and of dissolving the second non-cross-linkable material.
29. A muscular and/or adipose tissue particle comprising a cross-linked edible gel material that is substantially spherical, with a diameter bigger than 1 mm, and at least 100,000 cells per crosslinked edible gel material outer surface area unit.
30. A meat product comprising muscular and/or adipose tissue particles of claim 29.
31. An equipment for enabling the cultured meat production process of claim 1, comprising: a) a mixer of gel material capable of mixing a first cell-loaded cross-linkable edible gel material with a second non-cross-linkable gel material to obtain a cell-gel mixture; b) an open container for cross-linking solution and/or culture media with separation means to remove the cross-linking solution and/or the culture media; c) dropping means located above the open container capable of supplying drops of the cell-gel mixture.
32. The equipment according to claim 31, wherein the mixer comprises mixture delivery fixtures allowing low flow rates enough to achieve dropping of the mixed cell-gel.
33. The equipment according to claim 32, wherein the mixer comprises an extrusion equipment further equipped with a head or dice for allowing droplets to fall.
34. The equipment according to claim 32, wherein the mixer is a motionless static mixer.
35. The equipment according to claim 32, wherein a plurality of mixers and/or mixture delivery fixtures are configured in parallel.
36. The equipment according to claim 31, wherein the separation means of the open container are selected between sieves and valves configured to enable the cell-gel or the meat-like tissue spheres to be kept into the container while the solution or the cell culture is removed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2022/054758 WO2023223083A1 (en) | 2022-05-20 | 2022-05-20 | Cultured meat production process, materials and equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2022/054758 WO2023223083A1 (en) | 2022-05-20 | 2022-05-20 | Cultured meat production process, materials and equipment |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023223083A1 true WO2023223083A1 (en) | 2023-11-23 |
Family
ID=88834739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/054758 WO2023223083A1 (en) | 2022-05-20 | 2022-05-20 | Cultured meat production process, materials and equipment |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023223083A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8703216B2 (en) * | 2011-07-26 | 2014-04-22 | The Curators Of The University Of Missouri | Engineered comestible meat |
US20150079238A1 (en) * | 2013-09-13 | 2015-03-19 | Francoise Suzanne Marga | Edible and animal-product-free microcarriers for engineered meat |
US20180185550A1 (en) * | 2017-01-05 | 2018-07-05 | The Regents Of The University Of Michigan | Microporous Hydrogel Scaffolds for Cell Transplantation |
WO2020123876A1 (en) * | 2018-12-12 | 2020-06-18 | Wild Type, Inc. | Synthetic food compositions |
WO2020152689A1 (en) * | 2019-01-26 | 2020-07-30 | Redefine Meat Ltd. | Meat analogues and methods of producing the same |
WO2020219755A1 (en) * | 2019-04-23 | 2020-10-29 | The Regents Of The University Of California | Methods and compositions for cell culture on heterogeneous scaffolds |
-
2022
- 2022-05-20 WO PCT/IB2022/054758 patent/WO2023223083A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8703216B2 (en) * | 2011-07-26 | 2014-04-22 | The Curators Of The University Of Missouri | Engineered comestible meat |
US20150079238A1 (en) * | 2013-09-13 | 2015-03-19 | Francoise Suzanne Marga | Edible and animal-product-free microcarriers for engineered meat |
US20180185550A1 (en) * | 2017-01-05 | 2018-07-05 | The Regents Of The University Of Michigan | Microporous Hydrogel Scaffolds for Cell Transplantation |
WO2020123876A1 (en) * | 2018-12-12 | 2020-06-18 | Wild Type, Inc. | Synthetic food compositions |
WO2020152689A1 (en) * | 2019-01-26 | 2020-07-30 | Redefine Meat Ltd. | Meat analogues and methods of producing the same |
WO2020219755A1 (en) * | 2019-04-23 | 2020-10-29 | The Regents Of The University Of California | Methods and compositions for cell culture on heterogeneous scaffolds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | 3D printed silk-gelatin hydrogel scaffold with different porous structure and cell seeding strategy for cartilage regeneration | |
KR101091084B1 (en) | Cell aggregate-hydrogel-polymer scaffold complex for cartilage regeneration, method for the preparation thereof and composition comprising the same | |
US20100297233A1 (en) | Oscillating cell culture bioreactor | |
CN111097068B (en) | Bionic hydroxyapatite powder/gelatin/sodium alginate composite 3D printing support and preparation method thereof | |
US11898159B2 (en) | Methods of making spheroids including biologically-relevant materials | |
US10760056B2 (en) | Three-dimensional co-culture method for adipocytes and macrophages | |
JP4575152B2 (en) | Porous gelatin material, gelatin structure, preparation method thereof and use thereof | |
EP1706103B1 (en) | Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix | |
CN103819694B (en) | A kind of silk fibroin hydrogel with cell compatibility and preparation method thereof | |
Nguyễn et al. | Alginate-silk fibroin Bioink: A printable hydrogel for tissue engineering | |
CN102350009A (en) | Preparation method of composite bone matrix gelatin polylactic acid porous bioactive material | |
US9260686B2 (en) | Tubular bioreactor system for use in bone and cartilage tissue engineering | |
WO2023223083A1 (en) | Cultured meat production process, materials and equipment | |
CN111304168A (en) | In-vivo tumor model for three-dimensional biological printing and construction method thereof | |
CN114887116B (en) | 3D printing bone defect repairing support loaded with mesenchymal stem cell extracellular matrix and preparation method thereof | |
Chen et al. | High-density culture of hepatocytes in a packed-bed bioreactor using a fibrous scaffold from plant | |
CN105802251B (en) | A kind of self assembly collagen template tissue engineering material and the preparation method and application thereof | |
KR20230034115A (en) | Porous scaffold containing plant protein and cultured meat prepared using the same | |
CN112972712A (en) | Novel hot-pressing sterilization program for processing biological ink and application of novel hot-pressing sterilization program in human liver organoid 3D model construction | |
Wierzbicka et al. | Optimization of the preparation process stages of the bioink compositions based on sodium alginate and gelatin to improve the viability of biological material contained in hydrogel 3D printouts | |
WO2024029629A1 (en) | Porous scaffold for cell culture and production method thereof | |
US20240074456A1 (en) | 3d-printable protein-enriched scaffolds | |
US20240108784A1 (en) | Hydrogel for cell-laden bioprinting, bioink, and preparation method and application thereof | |
CN114369565B (en) | Method for efficiently producing extracellular vesicles | |
CN113201525B (en) | Stem cell microsphere group, stem cell in-vitro amplification method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22942565 Country of ref document: EP Kind code of ref document: A1 |